Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ketamine+betaine microneedle patch - PharmaTher

Next Previous
X
Search
Drug Profile

Ketamine+betaine microneedle patch - PharmaTher

Alternative Names: KETABET™; KETABET™ MN patch; ketamine+betaine anhydrous - PharmaTher; KETAPATCHTM

Latest Information Update: 28 Jul 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator National Health Research Institutes
  • Developer PharmaTher
  • Class Analgesics; Antidepressants; Cyclohexanes; General anaesthetics; Quaternary ammonium compounds; Small molecules; Trimethyl ammonium compounds
  • Mechanism of Action AMPA receptor agonists; Methyltransferase stimulants; NMDA receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Depressive disorders
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Neuropathic pain; Postoperative pain
  • No development reported Depressive disorders

Most Recent Events

  • 28 Jul 2024 No recent reports of development identified for phase-I development in Depressive disorders in Canada (Transdermal, Patch)
  • 29 Jun 2022 PharmaTher plans to initiate phase II clinical studies to study KETABET™ microneedle patch in Depression and Neuropathic pain (Combination therapy) (Transdermal, Patch) in Q4 2022
  • 16 Feb 2022 PharmaTher Holdings has patent protection for Ketamine+betaine microneedle patch in USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top